•Efficacy and Safety of Risankizumab Among Patients With Ulcerative Colitis in East Asia: A Post Hoc Analysis of Two Randomized Clinical Trials
•Shared decision making in inflammatory bowel disease: a qualitative study with patients, gastroenterologists, and nurses
•Risk factors and prediction model of renal dysfunction in patients with inflammatory bowel disease: a retrospective cohort study
•Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update
•Is hemorrhoidal surgery really unsafe in inflammatory bowel disease? Results from the HEAD-IBD multicenter study on behalf of IG-IBD
